205 related articles for article (PubMed ID: 1540731)
1. Specificity of screening in United Kingdom trial of early detection of breast cancer.
BMJ; 1992 Feb; 304(6823):346-9. PubMed ID: 1540731
[TBL] [Abstract][Full Text] [Related]
2. Impact of false-positive mammography on subsequent screening attendance and risk of cancer.
McCann J; Stockton D; Godward S
Breast Cancer Res; 2002; 4(5):R11. PubMed ID: 12223128
[TBL] [Abstract][Full Text] [Related]
3. How reassuring is a normal breast ultrasound in assessment of a screen-detected mammographic abnormality? A review of interval cancers after assessment that included ultrasound evaluation.
Bennett ML; Welman CJ; Celliers LM
Clin Radiol; 2011 Oct; 66(10):928-39. PubMed ID: 21718976
[TBL] [Abstract][Full Text] [Related]
4. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
[TBL] [Abstract][Full Text] [Related]
5. Comparison of screening mammography in the United States and the United kingdom.
Smith-Bindman R; Chu PW; Miglioretti DL; Sickles EA; Blanks R; Ballard-Barbash R; Bobo JK; Lee NC; Wallis MG; Patnick J; Kerlikowske K
JAMA; 2003 Oct; 290(16):2129-37. PubMed ID: 14570948
[TBL] [Abstract][Full Text] [Related]
6. Changing to core biopsy in an NHS breast screening unit.
Britton PD; Flower CD; Freeman AH; Sinnatamby R; Warren R; Goddard MJ; Wight DG; Bobrow L
Clin Radiol; 1997 Oct; 52(10):764-7. PubMed ID: 9366536
[TBL] [Abstract][Full Text] [Related]
7. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography.
Laya MB; Larson EB; Taplin SH; White E
J Natl Cancer Inst; 1996 May; 88(10):643-9. PubMed ID: 8627640
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of core biopsy for screen-detected breast lesions under 10 mm: implications for surgical management.
Farshid G; Downey P; Pieterse S; Gill PG
ANZ J Surg; 2017 Sep; 87(9):725-731. PubMed ID: 25776551
[TBL] [Abstract][Full Text] [Related]
9. The contribution of clinical breast examination to the accuracy of breast screening.
Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
[TBL] [Abstract][Full Text] [Related]
10. Long-term risk of false-positive screening results and subsequent biopsy as a function of mammography use.
Blanchard K; Colbert JA; Kopans DB; Moore R; Halpern EF; Hughes KS; Smith BL; Tanabe KK; Michaelson JS
Radiology; 2006 Aug; 240(2):335-42. PubMed ID: 16864665
[TBL] [Abstract][Full Text] [Related]
11. Crude open biopsy rates for benign screen detected lesions no longer reflect breast screening quality--time to change the standard.
Maxwell AJ; Pearson JM; Bishop HM
J Med Screen; 2002; 9(2):83-5. PubMed ID: 12133928
[TBL] [Abstract][Full Text] [Related]
12. Interval Breast Cancer Rates and Histopathologic Tumor Characteristics after False-Positive Findings at Mammography in a Population-based Screening Program.
Hofvind S; Sagstad S; Sebuødegård S; Chen Y; Roman M; Lee CI
Radiology; 2018 Apr; 287(1):58-67. PubMed ID: 29239711
[TBL] [Abstract][Full Text] [Related]
13. Mammography of women with suspicious breast lumps.
Young JO; Sadowsky NL; Young JW; Herman L
Arch Surg; 1986 Jul; 121(7):807-9. PubMed ID: 3718215
[TBL] [Abstract][Full Text] [Related]
14. Performance goals for an adjunct diagnostic test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences.
Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
J Am Coll Radiol; 2013 Dec; 10(12):924-30. PubMed ID: 24295942
[TBL] [Abstract][Full Text] [Related]
15. Breast screening using 2D-mammography or integrating digital breast tomosynthesis (3D-mammography) for single-reading or double-reading--evidence to guide future screening strategies.
Houssami N; Macaskill P; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Ciatto S
Eur J Cancer; 2014 Jul; 50(10):1799-1807. PubMed ID: 24746887
[TBL] [Abstract][Full Text] [Related]
16. Second round cancers: how many were visible on the first round of the UK National Breast Screening Programme, three years earlier?
Daly CA; Apthorp L; Field S
Clin Radiol; 1998 Jan; 53(1):25-8. PubMed ID: 9464431
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic Breast Biopsy With Benign Results Does Not Negatively Affect Future Screening Adherence.
Lewin AA; Gao Y; Lin Young LL; Albert ML; Babb JS; Toth HK; Moy L; Heller SL
J Am Coll Radiol; 2018 Apr; 15(4):622-629. PubMed ID: 29433804
[TBL] [Abstract][Full Text] [Related]
18. Referral policy and positive predictive value of call for surgical biopsy in the Florence Breast Cancer Screening Program.
Ciatto S; Cecchini S; del Turco MR; Grazzini G; Iossa A; Bartoli D
J Clin Epidemiol; 1990; 43(5):419-23. PubMed ID: 2182788
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer screening by mammography in women aged under 50 years in Japan.
Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
